Sürekli Renal Replasman Tedavisinde Kullanılan Membran ve Filtreler

Ahrenholz PG, Winkler RE, Michelsen A, Lang DA, Bowry SK. Dialysis membrane-dependent removal of middle molecules during hemodiafiltration: the beta2-microglobulin/albumin relationship. Clin Nephrol 2004;62(1):21-8.
Davenport A. Membrane designs and composition for hemodialysis, hemofiltration and hemodiafiltration: past, present and future. Minerva Urol Nefrol 2010;62:29-40.
Huang Z, LetteriJJ, Ronco C, Clark WR. Chapter 14: The Membrane Size and Material. Kellum JA, Bellomo R, Ronco C, eds. Continuous Renal Replacement Therapy. 2nd ed. Oxford, 2016:117-24.
Palmer SC, Rabindranath KS, Craig JC, Roderick PJ, Locatelli F, Strippoli GF. High-flux versus low-flux membranes for end-stage kidney disease. Cochrane Database Syst Rev 2012;9:CD005016.
Tomo T. Flux of Dialysis Membrane: Benefit and Risk. Kim YL, Kawanishi H, eds. The Essentials of Clinical Dialysis 1 st ed. Singapore: Springer; 2018:81-4.
Zweigert C, Neubauer M, Storr M, et al. Chapter 2: Progress in the development of membranes for kidney-replacement therapy. Drioli E, Giorno L, eds. Comprehensive Membrane Science and Engineering.1st ed. UK: Elsevier; 2013: 351-87.